- How do we achieve product–market fit across clinical, economic, and real-world adoption?
- How do we build a scalable sales model that drives adoption among patients, providers, and payers?
- Should we launch as a wellness device first, and when should we transition to a prescription-based model?

Great products rarely “sell themselves” in MedTech. Your commercialization strategy is what turns a validated product into repeatable, scalable sales. We help MedTech teams design and execute commercialization strategies that align with their exit goals, regulatory path, and real world customer behavior.
We work with you to build the strategy from start to finish or help address gaps pre-sales, post-revenue generation or provide objective external review/perspective to current approach. What we focus on:
Growth Objectives: Define clear exit and valuation targets, then translate them into near term sales goals and milestones investors will recognize.
Market, Customers, and Problems: Identify primary and secondary markets, the stakeholders who must say “yes,” and the specific clinical and operational problems you solve.
Product and Value Positioning: Clarify your value proposition and back it with clinical data, real world evidence, and usability proof that matter to buyers and regulators.
Regulatory, Go-to-Market Sales Model, and Channels: Align regulatory and compliance requirements with the right go-to-market sales model (direct, distributor, hybrid) and map the customer’s procurement journey.
Activation and Delivery: Design marketing, pricing, deployment, training, and post sale support so early deployments succeed and can be scaled.

Copyright © 2023 ElioMedica - All Rights Reserved.